There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
During an influenza A(H7N7) virus outbreak among poultry in Italy during August–September
2013, infection with a highly pathogenic A(H7N7) avian influenza virus was diagnosed
for 3 poultry workers with conjunctivitis. Genetic analyses revealed that the viruses
from the humans were closely related to those from chickens on affected farms.
In 1997, an H5N1 influenza A virus was transmitted from birds to humans in Hong Kong, killing 6 of the 18 people infected. When mice were infected with the human isolates, two virulence groups became apparent. Using reverse genetics, we showed that a mutation at position 627 in the PB2 protein influenced the outcome of infection in mice. Moreover, high cleavability of the hemagglutinin glycoprotein was an essential requirement for lethal infection.
An outbreak of highly pathogenic avian influenza A virus subtype H7N7 started at the end of February, 2003, in commercial poultry farms in the Netherlands. Although the risk of transmission of these viruses to humans was initially thought to be low, an outbreak investigation was launched to assess the extent of transmission of influenza A virus subtype H7N7 from chickens to humans. All workers in poultry farms, poultry farmers, and their families were asked to report signs of conjunctivitis or influenza-like illness. People with complaints were tested for influenza virus type A subtype H7 (A/H7) infection and completed a health questionnaire about type of symptoms, duration of illness, and possible exposures to infected poultry. 453 people had health complaints--349 reported conjunctivitis, 90 had influenza-like illness, and 67 had other complaints. We detected A/H7 in conjunctival samples from 78 (26.4%) people with conjunctivitis only, in five (9.4%) with influenza-like illness and conjunctivitis, in two (5.4%) with influenza-like illness only, and in four (6%) who reported other symptoms. Most positive samples had been collected within 5 days of symptom onset. A/H7 infection was confirmed in three contacts (of 83 tested), one of whom developed influenza-like illness. Six people had influenza A/H3N2 infection. After 19 people had been diagnosed with the infection, all workers received mandatory influenza virus vaccination and prophylactic treatment with oseltamivir. More than half (56%) of A/H7 infections reported here arose before the vaccination and treatment programme. We noted an unexpectedly high number of transmissions of avian influenza A virus subtype H7N7 to people directly involved in handling infected poultry, and we noted evidence for person-to-person transmission. Our data emphasise the importance of adequate surveillance, outbreak preparedness, and pandemic planning.
Amantadine (1-aminoadamantane hydrochloride) is effective in the prophylaxis and treatment of influenza A infections. In tissue culture this selective, strain-specific antiviral activity occurs at relatively low concentrations (5 microM or less), which inhibit either the initiation of infection or virus assembly. The data reported here demonstrate that the basis of these actions is similar and resides in the virus-coded M2 membrane protein, the product of a spliced transcript of RNA segment 7. Mutations which confer resistance to amantadine are restricted to four amino acids within a hydrophobic sequence, indicating that the drug is targetted against the putative membrane-associated portion of the molecule. The influence of the virus haemagglutinin on the amantadine sensitivity of virus strains implies that the drug may interfere with interactions between these two virus proteins.
Publisher:
Centers for Disease Control and Prevention
ISSN
(Print):
1080-6040
ISSN
(Electronic):
1080-6059
Publication date
(Print):
October
2014
Volume: 20
Issue: 10
Pages: 1745-1749
Affiliations
[1]Istituto Superiore di Sanità, Rome, Italy (S. Puzelli, M. Facchini, G. Vaccari, L.
Di Trani, A. Di Martino, G. Rezza, M.R. Castrucci, I. Donatelli);
[2]St. Orsola University Hospital, Bologna, Italy (G. Rossini, P. Gaibani, C. Vocale,
M.P. Landini);
[3] Istituto Zooprofilattico delle Venezie, Padua, Italy (G. Cattoli);
[4]Medical Research Council National Institute for Medical Research, London, UK (M. Bennett,
J.W. McCauley);
[5]Emilia-Romagna Region, Bologna (M.L. Moro, R. Rangoni, A.C. Finarelli)
Author notes
Address for correspondence: Simona Puzelli, National Influenza Centre, Department
of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità,
Viale Regina Elena, 299-00161 Roma, Italy; email:
simona.puzelli@
123456iss.it
Article
Publisher ID:
14-0512
DOI: 10.3201/eid2010.140512
PMC ID: 4193179
PubMed ID: 25271444
SO-VID: 543324e5-47af-4d29-b7cb-90652660e9e3
History
Categories
Subject:
Dispatch
Subject:
Dispatch
Subject:
Human Infection with Highly Pathogenic A(H7N7) Avian Influenza Virus, Italy, 2013
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.